j̶̶a̶̶m̶̶m̶̶i̶̶n̶̶g̶̶ ̶̶t̶̶h̶̶e̶̶ ̶̶n̶̶e̶̶x̶̶u̶̶s̶̶ ̶̶w̶̶i̶̶t̶̶h̶̶ ̶̶c̶̶o̶̶p̶̶y̶̶/̶̶p̶̶a̶̶s̶̶t̶̶e̶̶ ̶̶p̶̶o̶̶s̶̶t̶̶s̶̶ ̶̶i̶̶s̶̶ ̶̶n̶̶o̶̶t̶̶ ̶̶a̶̶ ̶̶b̶̶r̶̶i̶̶g̶̶h̶̶t̶̶ ̶̶i̶̶d̶̶e̶̶a̶̶.̶̶.̶̶.̶̶i̶̶m̶̶e̶̶ ̶̶t̶̶h̶̶a̶̶t̶̶ ̶̶w̶̶o̶̶n̶̶'̶̶t̶̶ ̶̶g̶̶e̶̶t̶̶ ̶̶y̶̶o̶̶u̶̶ ̶̶c̶̶l̶̶o̶̶s̶̶e̶̶r̶̶ ̶̶t̶̶o̶̶ ̶̶y̶̶o̶̶u̶̶r̶̶ ̶̶p̶̶r̶̶o̶̶m̶̶o̶̶t̶̶i̶̶o̶̶n̶̶ ̶̶e̶̶i̶̶t̶̶h̶̶e̶̶r̶̶?̶

I̶̶'̶̶d̶̶ ̶̶t̶̶r̶̶y̶̶ ̶̶t̶̶o̶̶ ̶̶f̶̶o̶̶c̶̶u̶̶s̶̶ ̶̶o̶̶n̶̶ ̶̶a̶̶ ̶̶w̶̶e̶̶l̶̶l̶̶ ̶̶w̶̶r̶̶i̶̶t̶̶t̶̶e̶̶n̶̶ ̶̶i̶̶n̶̶t̶̶r̶̶o̶̶d̶̶u̶̶c̶̶t̶̶i̶̶o̶̶n̶̶ ̶̶e̶̶s̶̶s̶̶a̶̶y̶̶ ̶̶o̶̶r̶̶ ̶̶a̶̶n̶̶ ̶̶e̶̶x̶̶p̶̶e̶̶r̶̶i̶̶e̶̶n̶̶c̶̶e̶̶ ̶̶r̶̶e̶̶p̶̶o̶̶r̶̶t̶̶.̶̶.̶̶.̶̶t̶̶h̶̶i̶̶n̶̶g̶̶s̶̶ ̶̶t̶̶h̶̶a̶̶t̶̶ ̶̶a̶̶r̶̶e̶̶ ̶̶e̶̶s̶̶s̶̶e̶̶n̶̶t̶̶i̶̶a̶̶l̶̶ ̶̶f̶̶o̶̶r̶̶ ̶̶u̶̶s̶̶ ̶̶a̶̶n̶̶d̶̶ ̶̶y̶̶o̶̶u̶̶ ̶̶s̶̶o̶̶ ̶̶a̶̶s̶̶ ̶̶t̶̶o̶̶ ̶̶g̶̶e̶̶t̶̶ ̶̶a̶̶c̶̶q̶̶u̶̶a̶̶i̶̶n̶̶t̶̶e̶̶d̶̶ ̶̶e̶̶a̶̶s̶̶i̶̶e̶̶r̶̶.̶̶Y̶̶o̶̶u̶̶ ̶̶s̶̶h̶̶o̶̶u̶̶l̶̶d̶̶ ̶̶n̶̶o̶̶t̶̶ ̶̶s̶̶t̶̶r̶̶e̶̶s̶̶s̶̶ ̶̶t̶̶o̶̶o̶̶ ̶̶m̶̶u̶̶c̶̶h̶̶ ̶̶a̶̶b̶̶o̶̶u̶̶t̶̶ ̶̶b̶̶e̶̶i̶̶n̶̶g̶̶ ̶̶p̶̶r̶̶o̶̶m̶̶o̶̶t̶̶e̶̶d̶̶.̶̶.̶̶i̶̶t̶̶ ̶̶w̶̶i̶̶l̶̶l̶̶ ̶̶c̶̶o̶̶m̶̶e̶̶ ̶̶i̶̶n̶̶ ̶̶t̶̶i̶̶m̶̶e̶

̶W̶̶e̶̶l̶̶c̶̶o̶̶m̶̶e̶̶ ̶̶t̶̶o̶̶ ̶̶t̶̶h̶̶e̶̶ ̶̶N̶̶e̶̶x̶̶!̶

̶P̶̶e̶̶a̶̶c̶̶e̶̶.̶

Psychedelics and Mental Health: A Population Study

Background

The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands of years. Over 30 million people currently living in the US have used LSD, psilocybin, or mescaline.
Objective

To evaluate the association between the lifetime use of psychedelics and current mental health in the adult population.

Method

Data drawn from years 2001 to 2004 of the National Survey on Drug Use and Health consisted of 130,152 respondents, randomly selected to be representative of the adult population in the United States. Standardized screening measures for past year mental health included serious psychological distress (K6 scale), mental health treatment (inpatient, outpatient, medication, needed but did not receive), symptoms of eight psychiatric disorders (panic disorder, major depressive episode, mania, social phobia, general anxiety disorder, agoraphobia, posttraumatic stress disorder, and non-affective psychosis), and seven specific symptoms of non-affective psychosis. We calculated weighted odds ratios by multivariate logistic regression controlling for a range of sociodemographic variables, use of illicit drugs, risk taking behavior, and exposure to traumatic events.

Results

21,967 respondents (13.4% weighted) reported lifetime psychedelic use. There were no significant associations between lifetime use of any psychedelics, lifetime use of specific psychedelics (LSD, psilocybin, mescaline, peyote), or past year use of LSD and increased rate of any of the mental health outcomes. Rather, in several cases psychedelic use was associated with lower rate of mental health problems.
Conclusion

We did not find use of psychedelics to be an independent risk factor for mental health problems.

Psychedelics and Mental Health: A Population Study

Psychedelics are indeed great for mental issues.

I don't think EVERYONE suffering mental problems should use psychedelics of course but those that know they can handle them but are experiencing depression or other problems should definitely consider them.

Here's a related article from Discovery: http://news.discovery.co...ms-depression-122301.htm

jamming the nexus with copy/paste posts is not a bright idea...ime that won't get you closer to your promotion either?

I'd try to focus on a well written introduction essay or an experience report...things that are essential for us and you so as to get acquainted easier.You should not stress too much about being promoted..it will come in time.

Welcome to the Nex!

Peace.

Psilocybin has been proving to be greatly effective in treating things like depression, anxiety, and even PTSD. I've heard that micro-dosing psilocybin on a regular basis has a lot of benefits but can't seem to find much in the way of formal studies, but there is a great deal of anecodotal evidence, and formal studies which report findings to support the hypothesis. Here's a related article from Discovery: http://news.discovery.co...ms-depression-122301.htm

Psychedelic agents have a long history of use by humans for their capacity to induce profound modifications in perception, emotion and cognitive processes. Despite increasing knowledge of the neural mechanisms involved in the acute effects of these drugs, the impact of sustained psychedelic use on the human brain remains largely unknown. Molecular pharmacology studies have shown that psychedelic 5-hydroxytryptamine (5HT)2A agonists stimulate neurotrophic and transcription factors associated with synaptic plasticity. These data suggest that psychedelics could potentially induce structural changes in brain tissue. Here we looked for differences in cortical thickness (CT) in regular users of psychedelics. We obtained magnetic resonance imaging (MRI) images of the brains of 22 regular users of ayahuasca (a preparation whose active principle is the psychedelic 5HT2A agonist N,N-dimethyltryptamine (DMT)) and 22 controls matched for age, sex, years of education, verbal IQ and fluid IQ. Ayahuasca users showed significant CT differences in midline structures of the brain, with thinning in the posterior cingulate cortex (PCC), a key node of the default mode network. CT values in the PCC were inversely correlated with the intensity and duration of prior use of ayahuasca and with scores on self-transcendence, a personality trait measuring religiousness, transpersonal feelings and spirituality. Although direct causation cannot be established, these data suggest that regular use of psychedelic drugs could potentially lead to structural changes in brain areas supporting attentional processes, self-referential thought, and internal mentation. These changes could underlie the previously reported personality changes in long-term users and highlight the involvement of the PCC in the effects of psychedelics.

A couple years ago, i was able to forage a large amount of ps cyanescens, and for close to a year, regularly micro dosed. I would eat a stern or a cap, barely above threshold dose, once every two weeks. It gave me the happiest, most productive year of recent memory.

The mood stabilization was noticeable and my depression was markedly improved. Yay mushrooms!